NCT01566292
- Conditions
- Benign Prostatic Enlargement (BPE), Benign Prostatic Hyperplasia (BPH), Genital Diseases, +5 more
- Locations
-
- Catholic University of Sacred Heart Rome, Italy
Clinical trial condition
Prostatic Hyperplasia
Explore clinical trials studying Prostatic Hyperplasia. Study availability and eligibility vary by location and protocol.
611 public trials
85 recruiting studies
Prostatic Hyperplasia trial results
Completed
Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
NCT00527605
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Wuhan, Hubei, China
- GSK Investigational Site Nanjing, Jiangsu, China
- GSK Investigational Site Hangzhou, Zhejiang, China
NCT00970632
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Adelaide, South Australia, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bentleigh East, Victoria, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bunbury, Western Australia, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nedlands, Western Australia, Australia
NCT00793819
- Conditions
- Genital Diseases, Genital Diseases, Male, Lower Urinary Tract Symptoms, +8 more
- Locations
-
- Watson Investigational Site Huntsville, Alabama, United States
- Watson Investigational Site Laguna Hills, California, United States
- Watson Investigational Site San Diego, California, United States
- Watson Investigational Site Aventura, Florida, United States
Completed
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
NCT00426777
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Southern Interior Medical Research Corporation Kelowna, British Columbia, Canada
- Dr. Cal Andreou Surrey, British Columbia, Canada
- Dr. Allan Patrick Fredericton, New Brunswick, Canada
- The Male/Female Health and Research Centre Barrie, Ontario, Canada
NCT00427817
- Conditions
- Adenoma, Prostatic, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Urology Department - University Hospital of Grenoble Grenoble, France
Completed
Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)
NCT01330927
- Conditions
- Benign Prostatic Hypertrophy (BPH), Genital Diseases, Genital Diseases, Male, +9 more
- Locations
-
- Early Phase Clinical Unit, PAREXEL International GmbH Berlin, Germany
NCT00855582
- Conditions
- Benign Prostatic Hyperplasia, Erectile Dysfunction, Genital Diseases, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anchorage, Alaska, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Mesa, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
NCT00472251
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
NCT00224107
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Huntsville, Alabama, United States
- Tucson, Arizona, United States
- Anaheim, California, United States
- Culver City, California, United States